Search results
Results from the WOW.Com Content Network
In 2001, Perlmutter left Merck and joined Amgen as the executive vice president and head of R&D from January 2001 to February 2012. In 2013, he replaced Peter S. Kim as the executive vice president and president of Merck Research Laboratories. [8] In 2020, he retired from Merck and was replaced by Dean Y. Li. [9]
Merck has named a new head of research. Roger Perlmutter steps into the roles of executive vice president and president of Merck Research Laboratories. He replace of the retiring Peter Kim ...
David Perlmutter (born December 31, 1954) is an American celebrity doctor, author, low-carbohydrate diet advocate and promoter of functional medicine. [1] [2] [3]Perlmutter has been widely criticized by dietitians and physicians for promoting misinformation about gluten-containing grains including whole grains which he argues are a main cause of many diseases including brain disorders.
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare ...
Julie Gerberding, Merck Chief Patient Officer and Former CDC Director joins Yahoo Finance’s On The Move to break down the company’s search for a coronavirus vaccine.
A director at Deloitte Services LP and co-author of The Three Rules: How Exceptional Companies Think, Michael Raynor joins The Fool to share his findings about what makes a company successful for ...
Merck & Co. is a former subsidiary of Merck, and currently an independent company Pages in category "Merck & Co. people" The following 27 pages are in this category, out of 27 total.
(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.